Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000318306-09-000032
Filing Date
2009-11-02
Accepted
2009-11-02 14:53:03
Documents
1
Period of Report
2008-02-04

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 20874
  Complete submission text file 0000318306-09-000032.txt   22727
Mailing Address 2600 N STEMMONS FRWY STE 176 DALLAS TX 75207
Business Address 2600 N STEMMONS FRWY STE 176 DALLAS TX 75207 2149055100
ACCESS PHARMACEUTICALS INC (Issuer) CIK: 0000318306 (see all company filings)

EIN.: 830221517 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address
Business Address
LUCI DAVID P (Reporting) CIK: 0001271123 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-15771 | Film No.: 091150829